Myeloproliferative Neoplasms

Top Story

Survival rates after HSCT have not improved among infants with malignant diseases

March 18, 2019
FDA News

FDA grants priority review to fedratinib for myelofibrosis

March 5, 2019
The FDA granted priority review to fedratinib for the treatment of patients with myelofibrosis. Fedratinib (Celgene) is a highly selective JAK2 inhibitor.
In the Journals

Expanded single cord blood unit decreases hematopoietic recovery time after transplantation

March 1, 2019
An ex vivo-expanded umbilical cord blood unit appeared safe and effective as a standalone hematopoietic stem cell graft, shortening time to neutrophil and platelet…

Two clinicians appointed to leadership roles with Atlantic Hematology Oncology

February 22, 2019
Two hematologists-oncologists have assumed key leadership roles at Atlantic Hematology Oncology, part of Atlantic Health System Cancer Care. Charles M. Farber
More Headlines »
CME ABIM MOC

Ace the Case: A 52-Year-Old Man with an Asymptomatic Neck Mass

There is no commercial support for this activity.

This educational activity will discuss the approach to diagnosis and management of a 52-year-old man who presents with…
More »
Video
Meeting News

VIDEO: Visiting expert program helps community providers learn about immuno-oncology

June 12, 2017
More »
CME ABIM MOC

Ace the Case: A 61-Year-Old Man With 43 Pack-Years of Cigarette Smoking Presents With a Cough, Generalized Weakness, and a 14-Pound Weight Loss Over the Past 10 Weeks

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss a 61-year-old man with 43 pack-years of cigarette…
More »